ANS National Agency (ANS) included in the list of procedures the multiplex PCR test quickly for the diagnosis of meningitis and encephalitis, capable of detecting microorganisms causing these diseases within 1 hour. The compulsory coverage of this procedure by the health plans will be valid from February 17, 2025.
In the world of the world of world brain (February 22), the news can alleviate the pain of those suffering from the disease. The rapid Multiplex PCR test for the diagnosis of meningitis and encephalitis, capable of detecting the microorganisms that the cause of these diseases within 1 hour has just been incorporated into the list of National Supplementary Health Agency (ANS) procedures, as published Regulatory resolution no. 627of February 14, 2025.
Meningitis and encephalitis are infections of the central nervous system that have a high risk of morbidity and mortality. Meningitis is an inflammatory process of menings, membranes surrounding the brain and spinal cord. Encephalitis is a serious inflammatory condition that affects the brain. The main causal agents of these diseases are bacteria, mushrooms, parasites and viruses.
The World Health Organization (WHO) estimates the occurrence of 1.2 million cases and 135,000 deaths for meningitis every year all over the world. By 2030, the goals WHO is eliminating the epidemics of bacterial meningitis – the most lethal form of the disease – and reducing the deaths of 70%and halves the number of cases. It is estimated that, in total, the strategy can save more than 200,000 lives per year and significantly reduce the disabilities caused by the disease. In Brazil, second bulletin From the Ministry of Health, between 2007 and 2020, 393,941 suspicious cases of meningitis and 265,644 cases of various causes were confirmed, being the most frequent viral meningitis followed by bacteria. Encephalitis is also configured as a significant health problem and can have a fatal result for each five cases.
The incorporation of this procedure by ANS allows the detection of multiple bacterial, viral and fungal agents that cause meningitis and encephalitis through the procedure “Infectious agents in encephalitis and meningitis – detection by means of a multiplex PCR panel in the CSF”.
Second relationship From Conditec, which has supported incorporation, one of the important points is the economic vitality of the use of the rapid multiplex PCR test associated with the conventional method compared to the use of the conventional method for the diagnosis of meningitis/encephalitis in patients with suspicions With suspicions. The days of hospitalization and the days of empirical treatment necessary until the diagnosis of meningitis and encephalitis have been considered benefits of the technology assessed.
In the economic evaluation presented in Conditec, the Multiplex PCR test presented better effectiveness in terms of costs with the reduction of the hospitalization time and the empirical treatment times for both the general population and for the pediatric population. The product led to a reduction in costs, as well as a day of hospitalization in the hospital avoided for the general population and two days for the pediatric population, respectively. Likewise, the empirical treatment with the use of the 12 -day multiplex PCR test has avoided hospitalization for the general population and four days for the pediatric.
The compulsory coverage is already valid
The compulsory coverage of this procedure by the health plans is valid from February 17, 2025, as published in the Federal Official Gazette.
Second Law 14.307/2022After the positive recommendation by the National Commission for the incorporation of technologies (CONITEC) for inclusion in the Unified Health System (Sus), it is determined that these technologies are incorporated into the ANS list within 60 days.
During the 618th ordinary meeting of the Collegiate Board (Dol), held on 10 February 2025 by Dipro (product qualification direction at ANS), article 14 of agenda Deals with the analysis of the health technologies recommended positively by Conditec from 22/09/2024 to 24/12/2024 for incorporation in the Sus.
Therefore, from February 17, 2025, as published in the Dou, additional Health will cover the multiplex PCR for multiple pathogens in a panel in the CSF, as detailed in Regulatory resolution ANS n. 627of February 14, 2025. This regulation modifies RN n. 465 and regulates the mandatory coverage of the procedure to detect infectious agents in encephalitis and meningitis.
Website: https://www.biomerieux.com.br
Source: Terra
Rose James is a Gossipify movie and series reviewer known for her in-depth analysis and unique perspective on the latest releases. With a background in film studies, she provides engaging and informative reviews, and keeps readers up to date with industry trends and emerging talents.
